chartexchange

Why GeneDx Holdings Stock Just Dropped 16.6%

The Motley Fool | Nov 10, 2026 4:46 PM EST

GeneDx Holdings (NASDAQ:WGS) stock fell 16.6% on Tuesday, Nov. 10, after the biotech company lowered its growth targets for the year. The S&P 500 and the Nasdaq Composite dropped 0.4% and 0.7%, respectively. The genetic testing company GeneDx reported Q3 results on Monday after the bell. Sales jumped 5% to $123.1 million -- in line with what Wall Street was looking for -- and margins improved slightly. Unfortunately, testing volume lagged expectations. The company delivered 32,134 exome and genome results -- the DNA tests that are its core business -- up 25%. The company had promised 29.2% or more. Continue reading

Read original article